Publications

Mirrione-Savin A, Aghili Pour H, Swarbrick N, Müller S, Bacquet C, Malard L, Murphy MF, Richard P, Davies J, Rowley M, Poles D, Sandid I, Funk MB, Narayan S, Tiberghien P, Schäfer R (2024): Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom.
B J Haem Oct 30 [Epub ahead of print].
Text

Fiedler SA, Meyer B, Aghili Pour H, Funk MB (2024): Versorgungssituation mit Blutkomponenten in Deutschland auf der Basis von Meldungen an das Paul-Ehrlich-Institut.
Hämotherapie 43: 4-8.
Text

Berg P, Heiden M, Müller S, Meyer B, Witzenhausen C, Ruppert-Seipp G, Kehr S, Funk MB (2024): A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data.
Vox Sang Jun 18 [Epub ahead of print].
Text

Fiedler SA, Henseler O, Hoffelner M, Doll M, Hutschenreuter G, Hoch J, Weinauer F, Humpe A, Funk MB, Hilger A (2023): Monitoring Blood Supply in Germany: A Regulatory Perspective.
Transfus Med Hemother 50: 129-134.
Text

Orru' S, Oberle D, Heiden M, Müller S, Krut O, Funk MB (2023): Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011–2020).
Transfus Med Hemother 50: 144-153.
Text

Himmelsbach K, Mueller S, Kress J, Fiedler SA, Miskey C, Ivics Z, Patek A, Chudy M (2023): Second hepatitis C virus transmission by blood components since introduction of mandatory NAT screening in Germany.
Transfusion 63: 339-347.
Text

Fiedler SA, Oberle D, Henseler O, Heiden M, Funk MB (2023): Follow-Up of Plasma Donors after Quarantine Storage: Results of a 5-Year Survey in Germany.
Transfus Med Hemother 50: 26-29.
Text

Richter E, Al Arashi D, Schulte B, Bode C, Marx B, Aldabbagh S, Schlüter C, Kümmerer BM, Oldenburg J, Funk MB, Putensen C, Schmithausen RM, Hartmann G, Eis-Hübinger A, Streeck H (2021): Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections.
Transfus Med Hemother 48: 154-159.
Text

Orru' S, Poetzsch K, Hoffelner M, Heiden M, Funk MB, Keller-Stanislawski B, Oberle D (2021): Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018).
Transfus Med Hemother 48: 272-283.
Text

Corman VM, Rabenau HF, Adams O, Oberle D, Funk MB, Keller-Stanislawski B, Timm J, Drosten C, Ciesek S (2020): SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
Transfusion 60: 1119-1122.
Online-Abstract

Scheiblauer H, Heiden M, Funk MB, Oberle D, Kreß J, Jork C, Chudy M (2020): Detection of hepatitis B virus infection in German blood donors 2008-2015.
Vox Sang 115: 152-161.
Text

Domanovíc D, Ushiro-Lamb, Compernolle V, Brusin S, Funk M, Gallian P, Georgsen J, Janssen M, Jiminez-Marco T, Knutson F, Liumbruno GM, Mali P, Marano G, Maryuningsih Y, Niederhauser C, Politis C, Pupella S, Rautmann G, Saadat K, Sandid I, Sousa AP, Vaglio S, Velati C, Verdun N, Vesga M, Rebulla P (2019): Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.
Blood Transfus 17: 433-448.
Online-Abstract

Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk MB (2019): Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015).
Vox Sang 114: 443-450.
Online-Abstract

Kamp C, Blümel J, Baylis SA, Bekeredjian-Ding I, Chudy M, Heiden M, Henseler O, Keller-Stanislawski B, de Vos AS, Funk MB (2018): Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study.
Vox Sang 113: 811-813.
Online-Abstract

Funk MB, Heiden M, Willkommen H, Aepfelbacher M, Bauerfeind U, Bekeredjian-Ding I, Blümel J, Burger R, Doll M, Gröner A, Gürtler L, Hildebrandt M, Jansen B, Offergeld R, Pauli G, Schlenkrich U, Schottstedt V, Seitz R, Stahl D, Strobel J (2018): Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit: Pathogen-Inaktivierungssysteme für Thrombozytenkonzentrate - Stellungnahme.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61: 874-893.
Text

Müller S, Oberle D, Drechsel-Bäuerle U, Pavel J, Keller-Stanislawski B, Funk MB (2018): Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review.
Transfus Med Hemother 45: 355-367.
Online-Abstract

Funk MB, Heiden M, Volkers P, Lohmann A, Keller-Stanislawski B (2015): Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).
Transfus Med Hemother 42: 240-246.
Online-Abstract

Bellac CL, Hottiger T, Jutzi MP, Bögli-Stuber K, Sänger M, Hanschmann KM, Keller-Stanislawski B, Funk MB (2015): The role of isoagglutinins in intravenous immunoglobulin–related hemolysis.
Transfusion 55: S13-S22.
Online-Abstract

Funk MB, Frech M, Lohmann A, Keller-Stanislawski B (2015): Recht – Hämovigilanz: Überblick über die gesetzlichen Vorgaben gegenüber der Bundesoberbehörde in Deutschland.
Transfusionsmedizin 5: 102-107.
Online-Abstract

Funk MB, Gross N, Gross S, Hunfeld A, Lohmann A, Guenay S, Hanschmann KM, Keller-Stanislawski B (2013): Thromboembolic events associated with immunoglobulin treatment.
Vox Sang 105: 54-64.
Online-Abstract

Funk MB, Guenay S, Lohmann A, Henseler O, Heiden M, Hanschmann KM, Keller-Stanislawski (2012): Benefit of transfusion-related acute lung injury risk-minimization measures - German haemovigilance data (2006-2010).
Vox Sang 102: 317-323.
Online-Abstract

Funk MB, Lohmann A, Guenay S, Henseler O, Heiden M, Hanschmann KM, Keller-Stanislawski B (2011): Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010).
Transfus Med Hemother 38: 266-271.
Online-Abstract

Funk MB, Günay S, Lohmann A, Henseler O, Keller-Stanislawski B (2010): Bewertung der Maßnahmen zur Reduktion schwerwiegender Transfusionsreaktionen (Hämovigilanzdaten von 1997 bis 2008).
Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 53: 347-356.
Online-Abstract Text

Keller-Stanislawski B, Reil A, Günay S, Funk MB (2010): Frequency and severity of transfusion-related acute lung injury - German haemovigilance data (2006-2007).
Vox Sang 98: 70-77.
Online-Abstract

Keller-Stanislawski B, Lohmann A, Günay S, Heiden M, Funk MB (2009): The German Haemovigilance System–reports of serious adverse transfusion reactions between 1997 and 2007.
Transfus Med 19: 340-349.
Online-Abstract

Graul A, Heiden M, Gräf K, Keller-Stanislawski B (2003): Hämovigilanz in Deutschland - Bericht an das Paul-Ehrlich-Institut über Verdachtsfälle von Transfusionsreaktionen im Beobachtungszeitraum Januar 1995 bis Dezember 2002.
Transfus Med Hemother 30: 232-238.
Online-Abstract

Graul A, Keller-Stanislawski B (1999): Hämovigilanz von Blutkomponenten: Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998.
Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 42: 143-149.
Online-Abstract Text

top